Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Baggott

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 20, 2001
Caveat emptor: editors bewareF X Vollenweider, R T Jones, M J Baggott
Brain Research|November 12, 1993
A high-dose methamphetamine regimen results in long-lasting deficits on performance of a reaction-time taskJ B Richards, M J Baggott, K E Sabol, et al.
Clinical Pharmacology and Therapeutics|June 3, 2011
Mechanisms and genetics of antipsychotic-associated weight gainS L Balt, G P Galloway, M J Baggott, et al.
Drug and Alcohol Dependence|November 2, 2010
Abnormal visual experiences in individuals with histories of hallucinogen use: a Web-based questionnaireM J Baggott, J R Coyle, E Erowid, et al.
Clinical Pharmacology and Therapeutics|July 1, 1996
Buprenorphine and naloxone interactions in opiate-dependent volunteersJ Mendelson, R T Jones, I Fernandez, et al.
Clinical Pharmacology and Therapeutics|September 22, 2010
Efficacy, safety, and ethics of cosmetic neurology far from settledK Flower, L Li, C-Y A Chen, et al.
Drug and Alcohol Dependence|March 12, 2013
Ketamine is associated with lower urinary tract signs and symptomsR Pal, S Balt, E Erowid, et al.
Therapeutic Advances in Psychopharmacology|October 6, 2025
Psychedelic-assisted therapy as a complex intervention: implications for clinical trial designS D Muthumaraswamy, M J Baggott, E E Schenberg, et al.
Clinical Pharmacology and Therapeutics|December 24, 2010
A randomized, placebo-controlled trial of sustained-release dextroamphetamine for treatment of methamphetamine addictionG P Galloway, R Buscemi, J R Coyle, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 20, 2001
Caveat emptor: editors bewareF X Vollenweider, R T Jones, M J Baggott
Brain Research|November 12, 1993
A high-dose methamphetamine regimen results in long-lasting deficits on performance of a reaction-time taskJ B Richards, M J Baggott, K E Sabol, et al.
Clinical Pharmacology and Therapeutics|June 3, 2011
Mechanisms and genetics of antipsychotic-associated weight gainS L Balt, G P Galloway, M J Baggott, et al.
Drug and Alcohol Dependence|November 2, 2010
Abnormal visual experiences in individuals with histories of hallucinogen use: a Web-based questionnaireM J Baggott, J R Coyle, E Erowid, et al.
Clinical Pharmacology and Therapeutics|July 1, 1996
Buprenorphine and naloxone interactions in opiate-dependent volunteersJ Mendelson, R T Jones, I Fernandez, et al.
Clinical Pharmacology and Therapeutics|September 22, 2010
Efficacy, safety, and ethics of cosmetic neurology far from settledK Flower, L Li, C-Y A Chen, et al.
Drug and Alcohol Dependence|March 12, 2013
Ketamine is associated with lower urinary tract signs and symptomsR Pal, S Balt, E Erowid, et al.
Therapeutic Advances in Psychopharmacology|October 6, 2025
Psychedelic-assisted therapy as a complex intervention: implications for clinical trial designS D Muthumaraswamy, M J Baggott, E E Schenberg, et al.
Clinical Pharmacology and Therapeutics|December 24, 2010
A randomized, placebo-controlled trial of sustained-release dextroamphetamine for treatment of methamphetamine addictionG P Galloway, R Buscemi, J R Coyle, et al.
Pageof 1